Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Eagle-eyed watchers of Deloitte’s annual reports on Big Pharma will have noticed a depressing trend—ever-increasing costs for developing drugs over the past decade as the return on investment sinks.
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
The orphan drug sector has long been clearing growth in the larger pharmaceutical market with booming sales. But, thanks to blockbuster meds across wider disease areas and other challenges, the lucrative market may soon slow down for the first time in years.
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
The Russian drug bulevirtide for the treatment of hepatitis will be exempt from customs duty and value added tax. This was reported to the TASS correspondent by the press service of the Great State Hural (Parliament) of Mongolia.
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The chairman of the Government of the Russian Federation Mikhail Mishustin said that in the last year life expectancy in the country has reached almost 73.5 years. This is the highest figure in the entire history of Russia. The official believes that it is important to do everything necessary to ensure the availability of quality treatment, including high-tech, using modern, breakthrough methods.
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Rapid technological advancements have reshaped various aspects of our world, prompting discussions on the value of human connection, particularly in patient care within the field of pharmacy. Interestingly, many technological innovations in pharmacy not only preserve but also enhance the pharmacist’s ability to connect with patients, fostering compassion, which is crucial for positive health outcomes. These advancements have significantly expanded pharmacists’ capacity for direct patient care.
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024
IMPACT CKD, a modeling analysis created by AstraZeneca, forecasted that up to 16.5% of the population will suffer from chronic kidney disease (CKD) by 2032 across the United States, Brazil, the United Kingdom, Spain, Germany, the Netherlands, China, and Australia, according to a press release from the company.
Microbial burden assessment of solid pharmaceutical products
22 April 2024
Employing an automated, alternative microbiological method (AMM) means water activity could be used as a microbial indicator for bioburden assessment in tablets and capsules, a study suggests.
Seasonal variation of microbial contamination in pharmaceutical cleanrooms
22 April 2024
With the outdoor environment being a primary contamination source in the pharmaceutical cleanroom, measures like good manufacturing practices (GMP) is key to reduce this risk, a paper asserts.
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The head of Rospotrebnadzor, Anna Popova, conveyed a message from Russian President Vladimir Putin during the first Russian-African international conference on the fight against infectious diseases, stating that residents of Africa are the most vulnerable to future epidemics among the entire global population. In this regard, Russia is ready to help Africa in the fight to suppress existing and prevent future epidemics, the address emphasizes.
The Russian government has expanded the list of vital and essential drugs
19 April 2024
The list of vital and essential medicines has been supplemented with new items. The list includes three combination drugs for the treatment of various viral and bacterial infections and infectious and inflammatory diseases. Both lists also include two new drugs from Biocad for patients with multiple sclerosis. All drugs included in the lists are produced in a full cycle in Russia.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024